MRCT Center Faculty Co-Director, Barbara Bierer, MD and MRCT Center Program Manager, Sylvia Baedorf Kassis, MPH talk health literacy issues in clinical research with Patient Engagement HIT.
Home
MRCT Center team members Hayat R. Ahmed, David H. Strauss and Barbara Bierer highlight the importance of “Committing to the Inclusion of Diverse Populations in Clinical Research” recently published in the Journal of Therapeutic Innovation & Regulatory Science. Read Now
The MRCT Center 2019 Impact Report is now available! Read about our progress to improve the integrity, safety, and rigor of global clinical trials.
Focus Areas
News
Jan 25, 2020
Featured on Science Friday: Dr. Deborah Zarin, MRCT Center Program Director of Advancing the Clinical Trial Enterprise
Listen to Dr. Deborah Zarin, MRCT Center Program Director of Advancing the Clinical Trial Enterprise and former director of ClinicalTrials.gov with Science Magazine journalist, Charles Piller on Science Friday discussing recent investigations on ClinicalTrials.gov reporting practices.
Dec 10, 2019
Financial Times awards MRCT Center Faculty Co-Director, Mark Barnes, “2019 Legal Innovator of the Year”
[New York, NY., December 9, 2019]– At the prestigious December 9 Financial Times “Innovative Lawyers” awards, an annual contest that honors elite law firms, companies and legal service providers, Mark Barnes, JD LLM Multi-Regional Clinical Trials Center Faculty Co-Director and health care partner at Ropes & Gray, was honored with the “Legal Innovator of the Year” award, given to […]
Jun 25, 2019
OptumLabs and MRCT Center Award Grants for Replication of Drug Clinical Trials Using Real-World Data
[CAMBRIDGE, Mass., June 25, 2019]– OptumLabs and the MRCT Center announced that two academic institutions were awarded grants to support replication of established clinical trials through the use of electronic health record (EHR) and claims data, which could help improve clinical trial design and drug development.
Events
-
Mar 09, 2020
Meeting of the Research, Development, and Regulatory Roundtable (R3)Discussion topics: (1) Foreign Influence in Clinical Research, and (2) Impact of Fraud and Abuse Laws on Clinical Research.
-
Apr 30, 2020
MRCT Center Bioethics CollaborativeDiscussion topic: Artificial Intelligence in Clinical Trials
-
Jul 07, 2020
Meeting of the Research, Development, and Regulatory Roundtable (R3)Discussion topic: TBD
Our efforts have resulted in the implementation of best practices, greater transparency, and improved safety for research participants in clinical trials.